Appikon for AgingResearch.News: Longevity

The fastest way to know what really works in longevity

Av PAPERFOOT AI PTE. LTD. · Sosialt
Debuts-poeng 76NyVær først med å vurdere

Hvorfor vi forventer det: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

AgingResearch.News: Longevity skjermbilde 1AgingResearch.News: Longevity skjermbilde 2AgingResearch.News: Longevity skjermbilde 3AgingResearch.News: Longevity skjermbilde 4AgingResearch.News: Longevity skjermbilde 5

Lignende Sosialt-apper

Se de beste

Kort fortalt

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Sammendrag fra Debuts, basert på oppføringen i App Store.

Om appen

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Spørsmål om AgingResearch.News: Longevity

Hva er AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
Er AgingResearch.News: Longevity gratis?
Ja. AgingResearch.News: Longevity er gratis å laste ned.
Hvilke enheter fungerer AgingResearch.News: Longevity på?
AgingResearch.News: Longevity fungerer på iPhone, iPad.
Hvilke språk er AgingResearch.News: Longevity tilgjengelig på?
AgingResearch.News: Longevity er tilgjengelig på 11 språk, blant annet tysk, engelsk, spansk, fransk, italiensk, japansk.
Hvem lager AgingResearch.News: Longevity?
AgingResearch.News: Longevity er laget av PAPERFOOT AI PTE. LTD.. Aldersgrensen i App Store er 12+.
Hva er alternativer til AgingResearch.News: Longevity?
Lignende apper på Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Slik vurderer folk den

Logg inn for å vurdere denne appen. Det ærlige svaret teller.

Ingen vurderinger ennå. Har du prøvd den? Vær den første til å vurdere.

Oppdagelsessignaler

Hvordan AI og folk oppdager AgingResearch.News: Longevity på Debuts
Klar for AIDelvis
78 % beskrevet for AI-matching
Kan oppdages nåLiveStrukturerte data på denne siden og Debuts API

Fortell oss hva du liker. Vi sender bare e-post når noe nytt passer, og utviklere legger ofte ved et tilbud til testere.

Hva slags apper
På min
Vis meg bare
Hvor ofte
Vi sender en lenke du må bekrefte. Du får ingenting før du har klikket på den.